Work

Sacituzumab govitecan in breast cancer patients – an evaluation of progression-free survival, overall survival, and hypersensitivity reactions in real-world patients

Year: 2026

Type: article

Study design: Observational Study

Source: Journal of Oncology Pharmacy Practice

DOI: 10.1177/10781552261423836

Authors: Kaitlyn Becker, Christopher Walczak, Jolly Patel

Institutions: Novant Health Forsyth Medical Center, Novant Health Presbyterian Medical Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129027655

FWCI:

Cites: 2

Cited by:

Related to: